VIP and galactosemia: A similar effect was observed by McDermott et al. [65], where the topical application of SP at doses in the range from 25 pg/mL to 250 μg/mL, alone or combined with IGF-1 or with vasoactive intestinal polypeptide (VIP), had no influence on corneal re-epithelialization in rats with galactosemia.